Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain

Cellular entry of SARS-CoV-2 requires the binding between the receptor-binding domain (RBD) of the viral Spike protein and the cellular angiotensin-converting enzyme 2 (ACE2). As such, RBD has become the major target for vaccine development, whereas RBD-specific antibodies are pursued as therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Huan, Zeng, Weihong, Meng, Xiangzhi, Huang, Xiaoxue, Yang, Yunru, Zhao, Dan, Zhou, Peigen, Wang, Xiaofang, Zhao, Changcheng, Sun, Yong, Wang, Peihui, Ou, Huichao, Hu, Xiaowen, Xiang, Yan, Jin, Tengchuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139655/
https://www.ncbi.nlm.nih.gov/pubmed/33658349
http://dx.doi.org/10.1128/JVI.02438-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139655/
https://www.ncbi.nlm.nih.gov/pubmed/33658349
http://dx.doi.org/10.1128/JVI.02438-20

Ejemplares similares